First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Episurf tar in pengar

Planerar två emissioner och anställer ny finanschef.

Acousorts styrelseordförande blir även vd för norsk läkemedelsutvecklare

Martin Olin, styrelseordförande för Lundabaserade medicinteknikbolaget Acousort, har nu även utsetts till vd för norska Bergen Bio. Han kommer att sköta bägge u...

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.

Infidelity produces faster sperms

Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.

Measure blood sugar without finger pricking

The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...

LEO Pharma - International Clinical Trial Manager

Hey Kurt Berndt...

... who is starting up a research center for youths in Saltsjöbaden.

Partnering offer for scientists and medics

For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Ten recieve the Venture Cup West Prize

At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.

Control of blood vessels can treat obesity

Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Printing sensors for biological samples

Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.

Grönt ljus för Hamlet – startar klinisk studie

Fritt fram för klinisk studie med bröstmjölksprotein mot blåscancer.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Harmony prevents dementia

People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.

Gel av spindeltrådsprotein utvecklas för biomedicinsk användning

Spindeltrådens märkliga egenskaper kommer till användning när svenska forskare undersöker nya, potentiella metoder för bland annat regenerativ medicin och läkem...

Orion cuts 205 jobs

The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.